Biotechnology in India is a sunrise sector within the Indian economy.[1] Agencies of the Government of India concerned with the biotechnology industry include the Department of Biotechnology and the proposed Biotechnology Regulatory Authority of India. As of 2022, the sector is valued at $80 billion.[2] Biotechnology in India is in a growth phase and the sector is expected to be valued at $150 billion by 2025 and surpass $300 billion in value by 2030.[2]


The first Indian biotechnology company to be established was Biocon, which was founded by Kiran Mazumdar-Shaw in 1978.[3] The Indian biotechnology industry formally began in 1986 with the establishment of the Department of Biotechnology (DBT) by the Ministry of Science and Technology.[4] From 1999, St. Joseph’s College, Irinjalakuda, Kerala is offering a government-aided B.Sc. Biotechnology program. It is the only institution in Kerala offering an aided graduation program in biotechnology.[5]


Department of Biotechnology

Main article: Department of Biotechnology

The Department of Biotechnology is an Indian government department under the Ministry of Science and Technology, responsible for administering development and commercialization in the field of modern biology and biotechnology in India. The DBT was also one of the world's first government departments that was established to focus solely on the biotechnology sector.[4]

Biotechnology Regulatory Authority of India

Main article: Biotechnology Regulatory Authority of India

The Biotechnology Regulatory Authority of India (BRAI) is a proposed regulatory body in India for uses of biotechnology products including genetically modified organisms (GMOs).[6] The institute was first suggested under the Biotechnology Regulatory Authority of India (BRAI) draft bill prepared by the Department of Biotechnology in 2008. Since then, it has undergone several revisions.[7]


Biologics and biosimilars manufactures

Several of the large Indian pharmaceutical companies also manufacture biologics and biosimilars. One of Biocon's subsidiaries, Biocon Biologics, manufactures biosimilars.[8][9] Intas Pharmaceuticals also manufactures biosimilars.[10] Dr. Reddy's Laboratories entered the biosimilars market in 2008.[11] Cipla entered the biosimilars market in 2010.[12] Aurobindo Pharma is focusing on developing biosimilars in various segments.[13] Enzene Biosciences is the biologics subsidiary of Alkem Laboratories.[14][15]

Reliance Life Sciences, owned by Mukesh Ambani, Asia's wealthiest man, manufactures biosimilars and other biopharmaceutical and pharmaceutical products.[16][17]

Vaccine manufactures

India is the world's largest vaccine maker as of 2020.[18] Indian vaccine manufactures include the Serum Institute of India (SII).[19] SII is the world's largest vaccine manufacturer.[20][21] Reliance Life Sciences, among other products, also manufactures vaccines.[22][23] Another established vaccine manufacturer is Bharat Biotech.[24] Hester Biosciences is Asia’s largest company that manufactures animal and poultry vaccines.[25]

Contract manufacturers, researchers and developers

Syngene International, is a subsidiary of Biocon and is a contact development and manufacturing organisation (CDMO) that, among other areas, offers CDMO services for biologics.[26][27] Laurus Bio is a subsidiary of Laurus Labs and was originally an independent company named Richcore, before Laurus Labs acquired Richcore and renamed it.[28][29] Laurus Bio, among other products and services, also offers CDMO services for microbial precision fermentation.[30] In 2021, Cipla entered into a joint venture with biopharmaceutical CDMO company Kemwell Biopharma, to develop, manufacture and commercialize biosimilars for global markets.[31] Concord Biotech, among other areas, offers contract research and manufacturing services for fermentation products.[32]

Active pharmaceutical ingredients

Concord Biotech manufactures, among other products, fermentation based complex active pharmaceutical ingredients.[33][34]


Tata Consultancy Services (TCS), one of the largest information technology companies in India, offers bioinformatics and biostatistics services.[35][36]

Other established companies


There have been an increasing number of startups being founded in the Indian biotechnology industry. In 2021, the total number of biotechnology startups stood at 5365, whereas in 2010, there were only 50 startups in the sector.[2] As of 2021, more than half of the biotechnology startups are being founded in the medical sector, however, other large sectors where biotechnology startups are being founded include 18% in the biotechnology services sector and 14% of startups are in agricultural biotechnology.[4]

Biotechnology parks

The DBT has set up biotechnology parks in India, and as of 2022, there are 9 biotechnology parks across the country.[39] The parks have been set up by the DBT to give infrastructure support that will assist in making biotechnology research into products and services.[39] The biotechnology parks give scientists and small and medium-sized enterprises facilities that can help them in developing and demonstrating technologies, and assist in their pilot plant studies as well.


  1. ^ Livemint (11 June 2022). "India's biotech sector likely to reach $150 billion in 4 years: Minister". mint. Retrieved 6 December 2022.
  2. ^ a b c Basu, Mohana (20 July 2022). "R&D investment in Indian biotech tripled in 2021 to cross $1 billion, says govt report". ThePrint. Retrieved 25 December 2022.
  3. ^ Dey, Soma (2019). "Biocon: Taking a Crack at the Global Biosimilar Market". South Asian Journal of Business and Management Cases. 8 (1): 100–110. doi:10.1177/2277977918803186. ISSN 2277-9779.
  4. ^ a b c Nogrady, Bianca (12 December 2018). "How Indian biotech is driving innovation". Nature. 564 (7735): S53–S55. doi:10.1038/d41586-018-07671-9. PMID 30542184.
  5. ^ "Department of Biotechnology, St. Joseph's College, Irinjalakuda".
  6. ^ Regulatory Authority to be Set Up on Bio-Technology, PIB, GOI, 22 May 2012
  7. ^ "BRAI Bill leaves biotech commercialisation in limbo", The Hindu, 9 September 2010
  8. ^ "Who we are - Biocon - Global Biopharmaceutical company". Biocon. Retrieved 11 September 2022.
  9. ^ Kumar, Manoj (24 May 2023). "India's Biocon Biologics says biosimilars put revenue on $1 bln trajectory". Reuters. Retrieved 8 August 2023.
  10. ^ BS Reporter (23 February 2015). "Ahmedabad-based Intas Pharma launches biosimilar in EU". Business Standard. Retrieved 17 August 2023.
  11. ^ "Dr Reddy's looks to biosimilars for growth". Generics and Biosimilars Initiative. 23 March 2012. Retrieved 21 August 2023.
  12. ^ "Cipla enters the biosimilars market". Generics and Biosimilars Initiative. 2 July 2010. Retrieved 21 August 2023.
  13. ^ Sharma, Neetu Chandra (13 September 2022). "Biosimilars has Pushed Aurobindo Pharma to Second Place Among Indian Pharma Companies. Can it Become No. 1?". Business Today. Retrieved 10 August 2023.
  14. ^ "Alkem launches first cetuximab similar biologic in India". Generics and Biosimilars Initiative. 13 June 2023. Retrieved 22 August 2023.
  15. ^ Roy, Shubhobrota Dev (30 January 2023). "Enzene snags $50 mn from parent firm, others". Mint. Retrieved 22 August 2023.
  16. ^ Gopalan, Krishna (31 July 2023). "Reliance Life Sciences: How a new campus in Nashik is helping the firm make the moves". Business Today. Retrieved 22 August 2023.
  17. ^ "Mukesh Ambani". Forbes. Retrieved 27 January 2023.
  18. ^ Roy, Abhirup; Rocha, Euan; Das, Krishna N. (10 December 2020). "Not without India: World's pharmacy gears up for vaccine race". Reuters. Retrieved 26 December 2022.
  19. ^ "About Serum Institute Of India Pvt. Ltd". Retrieved 6 September 2022.
  20. ^ Kalra, Aditya (24 May 2022). "Indian vaccine giant Serum plans African plant in global expansion". Reuters. Retrieved 6 September 2022.
  21. ^ Robertson, Chiyo (28 February 2021). "Covid: How this Indian firm is vaccinating the world". BBC News. Retrieved 6 September 2022.
  22. ^ Bl Bengaluru Bureau (21 August 2023). "ABB India to automate Reliance Life Sciences' biopharmaceutical facilities". The Hindu Business Line. Retrieved 22 August 2023.
  23. ^ Sharma, Priyanka (2 November 2022). "ICMR picks 6 firms for monkeypox vaccines". Mint. Retrieved 22 August 2023.
  24. ^ "Bharat Biotech International Ltd - Company Profile and News". Retrieved 6 September 2022.
  25. ^ "About". Retrieved 6 October 2022.
  26. ^ "Syngene International Ltd". Contract Pharma. Retrieved 7 August 2023.
  27. ^ TNN (6 July 2023). "Syngene to acquire Unit 3's biologics facility". The Times of India. ISSN 0971-8257. Retrieved 7 August 2023.
  28. ^ Ramarathinam, Ashwin (25 November 2020). "Laurus Labs buys 73% stake in Biotech firm Richcore Lifesciences for Rs247 crore". mint. Retrieved 2 May 2022.
  29. ^ "Laurus Bio | Enabling precision fermentation and synthetic biology". LAURUS Bio. Retrieved 2 May 2022.
  30. ^ "CDMO Services". Laurus Bio. Retrieved 22 August 2023.
  31. ^ "Cipla, Kemwell Enter Biosimilars Joint Venture". Contract Pharma. 30 August 2021. Retrieved 22 August 2023.
  32. ^ "Contract Research & Manufacturing". Concord Biotech. Retrieved 30 August 2023.
  33. ^ "About us". Concord Biotech. Retrieved 4 August 2023.
  34. ^ Manohar, Asit (5 August 2023). "Concord Biotech IPO: What GMP, subscription signal as offer ends on Tuesday". Mint. Retrieved 30 August 2023.
  35. ^ "TCS' cutting-edge Genomics Research Services". TATA Consultancy Services. Retrieved 6 September 2023.
  36. ^ Reymond, Emilie (4 September 2007). "Tata bags major BPO deal with Roche". Outsourcing-Pharma. Retrieved 25 September 2023.
  37. ^ "Corporate Profile". Advanced Enzymes. Retrieved 6 October 2022.
  38. ^ How Bengaluru became the biotech capital of India, The Economic Times, 12 November 2015
  39. ^ a b PTI (28 May 2022). "North India's first biotech park inaugurated in J-K's Kathua". The Economic Times. Retrieved 28 December 2022.